EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 24 June 2026. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 5.28 for October-December 2025 as against Tk. 4.10 for October-December 2024; Consolidated EPS was Tk. 10.58 for July-December 2025 as against Tk. 7.87 for July-December 2024. Consolidated NOCFPS was Tk. 11.16 for July-December 2025 as against Tk. 6.13 for July-December 2024. Consolidated NAV per share was Tk. 129.63 as on December 31, 2025 and Tk. 111.35 as on December 31,2024. Reasons for deviations: (cont.1)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6a3b542400e9a19e44fa3834
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.